It has been postulated that the complex interplay between IL-10 and IFN-γ might regulate the immunosuppressive effect of indolamine 2,3-dioxygenase (IDO) tryptophan metabolism by glioma-associated APCs, resulting in a stronger anti-tumor immune response (208). The gene discussed is IL10; the disease is glioma.